When it comes to advancements in the care and treatment of Parkinson’s, research is a key component to inform and influence the way therapies are trusted, adopted, prescribed, and followed. But what happens when access to participation in research and even the design of investigations neglects to consider a diverse audience These are a few of the many topics discussed in this conversation between Jonathan Jackson, PhD, and Nabila Dahodwala, MD.
Nabila Dahodwala
We are delighted to announce the creation of The Davis Phinney Foundation Inclusion, Diversity, Equity, and Access (IDEA) Advisory Board….